Sectoral Asset Management’s Aligos Therapeutics ALGS Stock Holding History

Sectoral Asset Management’s Portfolio ALGS Stock Details ALGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-676	Closed	-$201K	–	108
2021 Q4	$201K	Hold	676	–	–	0.03%	106
2021 Q3	$262K	Hold	676	–	–	0.02%	127
2021 Q2	$345K	Sell	676 -72	-10%	-$45.9K	0.03%	121
2021 Q1	$425K	Hold	748	–	–	0.03%	104
2020 Q4	$517K	Buy	+748	New	+$364K	0.04%	92

Other funds holding ALGS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sectoral Asset Management's ALGS Position: Q1 2022 in Review

Sectoral Asset Management sold out of Aligos Therapeutics (ALGS) in Q1 2022, closing a stake of 676 shares — an estimated $201K sold.

Sectoral Asset Management first reported a position in ALGS in Q4 2020 and held it in 5 quarters. The position peaked at $517K in Q4 2020. 76 funds tracked by Wall St. Rank hold ALGS as of Q1 2022.

Sectoral Asset Management reported no remaining Aligos Therapeutics position as of Q1 2022 after selling out during the quarter.
Sectoral Asset Management sold 676 Aligos Therapeutics shares in Q1 2022, an estimated $201K.
Sectoral Asset Management first reported a position in Aligos Therapeutics in Q4 2020 and held it in 5 quarters.
Sectoral Asset Management's Aligos Therapeutics position peaked at $517K in Q4 2020.
76 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2022.

Based on Sectoral Asset Management's 13F filing for Q1 2022, filed 10 May 2022.